Literature DB >> 18852279

Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.

Hiromi Sato1, Jimmy B Feix.   

Abstract

Lysine-enriched analogs of the cecropin-mellitin hybrid peptide, CA(1-7) M(2-9) (designated CM15), designed with optimized amphipathicity, retained antimicrobial activities similar to that of wild-type CM15 and had substantially reduced levels of hemolytic activity and cytotoxicity toward cultured macrophages, resulting in enhanced selectivity. These lysine-enriched analogs provide templates for improved CM15 peptide or peptidomimetic antibiotics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852279      PMCID: PMC2592880          DOI: 10.1128/AAC.00810-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  The structure of the mammalian antibacterial peptide cecropin P1 in solution, determined by proton-NMR.

Authors:  D Sipos; M Andersson; A Ehrenberg
Journal:  Eur J Biochem       Date:  1992-10-01

2.  In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics.

Authors:  Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Giuseppina D'Amato; Carmela Silvestri; Maria Simona Del Prete; Jerzy Lukasiak; Giorgio Scalise
Journal:  Diagn Microbiol Infect Dis       Date:  2004-07       Impact factor: 2.803

Review 3.  The nervous system and innate immunity: the neuropeptide connection.

Authors:  Kim A Brogden; Janet M Guthmiller; Michel Salzet; Michael Zasloff
Journal:  Nat Immunol       Date:  2005-06       Impact factor: 25.606

Review 4.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

5.  Two-dimensional proton-NMR studies on a hybrid peptide between cecropin A and melittin. Resonance assignments and secondary structure.

Authors:  D Sipos; K Chandrasekhar; K Arvidsson; A Engström; A Ehrenberg
Journal:  Eur J Biochem       Date:  1991-07-15

6.  Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.

Authors:  D Andreu; J Ubach; A Boman; B Wåhlin; D Wade; R B Merrifield; H G Boman
Journal:  FEBS Lett       Date:  1992-01-20       Impact factor: 4.124

7.  The solution conformation of the antibacterial peptide cecropin A: a nuclear magnetic resonance and dynamical simulated annealing study.

Authors:  T A Holak; A Engström; P J Kraulis; G Lindeberg; H Bennich; T A Jones; A M Gronenborn; G M Clore
Journal:  Biochemistry       Date:  1988-10-04       Impact factor: 3.162

8.  Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.

Authors:  José María Saugar; María Jesús Rodríguez-Hernández; Beatriz G de la Torre; María Eugenia Pachón-Ibañez; María Fernández-Reyes; David Andreu; Jerónimo Pachón; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

9.  Hydrophobic effects on antibacterial and channel-forming properties of cecropin A-melittin hybrids.

Authors:  P Juvvadi; S Vunnam; E L Merrifield; H G Boman; R B Merrifield
Journal:  J Pept Sci       Date:  1996 Jul-Aug       Impact factor: 1.905

10.  Induced conformational states of amphipathic peptides in aqueous/lipid environments.

Authors:  S E Blondelle; J M Ostresh; R A Houghten; E Pérez-Payá
Journal:  Biophys J       Date:  1995-01       Impact factor: 4.033

View more
  11 in total

1.  Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.

Authors:  Seiichi Taguchi; Kensuke Mita; Kenta Ichinohe; Shigeki Hashimoto
Journal:  Appl Environ Microbiol       Date:  2008-12-29       Impact factor: 4.792

2.  Effects of D-Lysine Substitutions on the Activity and Selectivity of Antimicrobial Peptide CM15.

Authors:  Heather M Kaminski; Jimmy B Feix
Journal:  Polymers (Basel)       Date:  2011-12-06       Impact factor: 4.329

3.  Using infrared spectroscopy of cyanylated cysteine to map the membrane binding structure and orientation of the hybrid antimicrobial peptide CM15.

Authors:  Katherine N Alfieri; Alice R Vienneau; Casey H Londergan
Journal:  Biochemistry       Date:  2011-12-02       Impact factor: 3.162

4.  Understanding the antimicrobial properties/activity of an 11-residue Lys homopeptide by alanine and proline scan.

Authors:  P Carvajal-Rondanelli; M Aróstica; C A Álvarez; C Ojeda; F Albericio; L F Aguilar; S H Marshall; F Guzmán
Journal:  Amino Acids       Date:  2018-02-21       Impact factor: 3.520

5.  Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci.

Authors:  Stephanie Sandiford; Mathew Upton
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

6.  Expression of recombinant hybrid peptide hinnavin II/alpha-melanocyte-stimulating hormone in Escherichia coli: purification and characterization.

Authors:  Son Kwon Bang; Chang Soo Kang; Man-Deuk Han; In Seok Bang
Journal:  J Microbiol       Date:  2010-03-11       Impact factor: 3.422

7.  Membrane fluidity, composition, and charge affect the activity and selectivity of the AMP ascaphin-8.

Authors:  Adriana Morales-Martínez; Brandt Bertrand; Juan M Hernández-Meza; Ramón Garduño-Juárez; Jesús Silva-Sanchez; Carlos Munoz-Garay
Journal:  Biophys J       Date:  2022-07-16       Impact factor: 3.699

8.  The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.

Authors:  Huang Jin-Jiang; Lu Jin-Chun; Lu Min; Huang Qing-Shan; Li Guo-Dong
Journal:  Int J Microbiol       Date:  2012-02-16

9.  Manipulating Active Structure and Function of Cationic Antimicrobial Peptide CM15 with the Polysulfonated Drug Suramin: A Step Closer to in Vivo Complexity.

Authors:  Mayra Quemé-Peña; Tünde Juhász; Judith Mihály; Imola Cs Szigyártó; Kata Horváti; Szilvia Bősze; Judit Henczkó; Bernadett Pályi; Csaba Németh; Zoltán Varga; Ferenc Zsila; Tamás Beke-Somfai
Journal:  Chembiochem       Date:  2019-05-20       Impact factor: 3.164

10.  Physicochemical-guided design of cathelicidin-derived peptides generates membrane active variants with therapeutic potential.

Authors:  Nelson G J Oliveira; Marlon H Cardoso; Nadya Velikova; Marcel Giesbers; Jerry M Wells; Taia M B Rezende; Renko de Vries; Octávio L Franco
Journal:  Sci Rep       Date:  2020-06-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.